These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The German Mouse Clinic: a platform for systemic phenotype analysis of mouse models. Fuchs H; Gailus-Durner V; Adler T; Pimentel JA; Becker L; Bolle I; Brielmeier M; Calzada-Wack J; Dalke C; Ehrhardt N; Fasnacht N; Ferwagner B; Frischmann U; Hans W; Hölter SM; Hölzlwimmer G; Horsch M; Javaheri A; Kallnik M; Kling E; Lengger C; Maier H; Mossbrugger I; Mörth C; Naton B; Nöth U; Pasche B; Prehn C; Przemeck G; Puk O; Racz I; Rathkolb B; Rozman J; Schäble K; Schreiner R; Schrewe A; Sina C; Steinkamp R; Thiele F; Willershäuser M; Zeh R; Adamski J; Busch DH; Beckers J; Behrendt H; Daniel H; Esposito I; Favor J; Graw J; Heldmaier G; Höfler H; Ivandic B; Katus H; Klingenspor M; Klopstock T; Lengeling A; Mempel M; Müller W; Neschen S; Ollert M; Quintanilla-Martinez L; Rosenstiel P; Schmidt J; Schreiber S; Schughart K; Schulz H; Wolf E; Wurst W; Zimmer A; Hrabé de Angelis M Curr Pharm Biotechnol; 2009 Feb; 10(2):236-43. PubMed ID: 19199957 [TBL] [Abstract][Full Text] [Related]
9. The Tennessee Mouse Genome Consortium: identification of ocular mutants. Jablonski MM; Wang X; Lu L; Miller DR; Rinchik EM; Williams RW; Goldowitz D Vis Neurosci; 2005; 22(5):595-604. PubMed ID: 16332270 [TBL] [Abstract][Full Text] [Related]
10. Screening for increased plasma urea levels in a large-scale ENU mouse mutagenesis project reveals kidney disease models. Aigner B; Rathkolb B; Herbach N; Kemter E; Schessl C; Klaften M; Klempt M; de Angelis MH; Wanke R; Wolf E Am J Physiol Renal Physiol; 2007 May; 292(5):F1560-7. PubMed ID: 17264314 [TBL] [Abstract][Full Text] [Related]
11. An ENU-induced mutation in Rs1h causes disruption of retinal structure and function. Jablonski MM; Dalke C; Wang X; Lu L; Manly KF; Pretsch W; Favor J; Pardue MT; Rinchik EM; Williams RW; Goldowitz D; Graw J Mol Vis; 2005 Jul; 11():569-81. PubMed ID: 16088326 [TBL] [Abstract][Full Text] [Related]
12. Metabolic phenotyping of mouse mutants in the German Mouse Clinic. Elvert R; Ehrhardt N; Taube M; Klingenspor M; Gailus-Durner V; Fuchs H; DE Angelis MH; Blanquet V; Heldmaer G Integr Zool; 2006 Sep; 1(3):122-5. PubMed ID: 21396004 [TBL] [Abstract][Full Text] [Related]
13. Generation of N-ethyl-N-nitrosourea-induced mouse mutants with deviations in plasma enzyme activities as novel organ-specific disease models. Aigner B; Rathkolb B; Klaften M; Sedlmeier R; Klempt M; Wagner S; Michel D; Mayer U; Klopstock T; de Angelis MH; Wolf E Exp Physiol; 2009 Apr; 94(4):412-21. PubMed ID: 19151073 [TBL] [Abstract][Full Text] [Related]
14. Diabetes models by screen for hyperglycemia in phenotype-driven ENU mouse mutagenesis projects. Aigner B; Rathkolb B; Herbach N; Hrabé de Angelis M; Wanke R; Wolf E Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E232-40. PubMed ID: 18056790 [TBL] [Abstract][Full Text] [Related]
15. Impact of brain-behavior phenotypying of genetically-engineered mice on research of neuropsychiatric disorders. Takao K; Yamasaki N; Miyakawa T Neurosci Res; 2007 Jun; 58(2):124-32. PubMed ID: 17524507 [TBL] [Abstract][Full Text] [Related]
16. Now and future of mouse mutagenesis for human disease models. Gondo Y J Genet Genomics; 2010 Sep; 37(9):559-72. PubMed ID: 20933210 [TBL] [Abstract][Full Text] [Related]
17. A chemical mutagenesis screen to identify modifier genes that interact with growth hormone and TGF-beta signaling pathways. Mohan S; Baylink DJ; Srivastava AK Bone; 2008 Feb; 42(2):388-95. PubMed ID: 18063435 [TBL] [Abstract][Full Text] [Related]